These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8982430)

  • 1. Effectiveness of 4% disodium cromoglycate in the treatment of disseminated pyoderma gangrenosum.
    Langenbach N; Goetz A; Hohenleutner U; Landthaler M
    Acta Derm Venereol; 1996 Nov; 76(6):501-2. PubMed ID: 8982430
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical treatment with 1% sodium cromoglycate in pyoderma gangrenosum.
    Tamir A; Landau M; Brenner S
    Dermatology; 1996; 192(3):252-4. PubMed ID: 8726641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local treatment of pyoderma gangrenosum with cromoglycate solution].
    Harvima RJ; Hollmén A; Mattila R; Kaipiainen-Seppänen O; Harvima IT; Kaminska R; Laukkanen A; Räsänen L; Horsmanheimo M
    Duodecim; 1999; 115(19):2085-90. PubMed ID: 11941802
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical disodium cromoglycate in the management of pyoderma gangrenosum.
    Massone L; Borghi S; Pestarino A; Gambini C
    Cutis; 1988 Nov; 42(5):459-62. PubMed ID: 3143520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pyoderma gangrenosum with disodium cromoglycate.
    Saffouri B; Hom BM; Mertesdorf JM; Gardiner JE
    Dig Dis Sci; 1984 Feb; 29(2):183-5. PubMed ID: 6421555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma gangrenosum associated with ulcerative colitis: treatment with disodium cromoglycate.
    Cave DR; Burakoff R
    Am J Gastroenterol; 1987 Aug; 82(8):802-4. PubMed ID: 3111244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pyoderma gangrenosum with 4% cromolyn.
    Anderson LL; Samlaska CP; Cardone JS; Holtzmuller KC
    Arch Dermatol; 1994 Sep; 130(9):1117-20. PubMed ID: 8085865
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of pyoderma gangrenosum.
    Mokni M; Phillips TJ
    Hosp Pract (1995); 2001 Apr; 36(4):40-4. PubMed ID: 11327344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of pyoderma gangrenosum with sodium cromoglycate.
    de Cock KM; Thorne MG
    Br J Dermatol; 1980 Feb; 102(2):231-3. PubMed ID: 6770886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical treatment of pyoderma gangraenosum.
    Wenzel J; Gerdsen R; Phillipp-Dormston W; Bieber T; Uerlich M
    Dermatology; 2002; 205(3):221-3. PubMed ID: 12399665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cromolyn sodium in 2% aqueous solution under an occlusive hydrocolloid dressing may be effective adjunctive treatment in management of pyoderma gangrenosum.
    Smith KC; Su WP; Leiferman KM
    J Am Acad Dermatol; 1987 Sep; 17(3):509-11. PubMed ID: 3116046
    [No Abstract]   [Full Text] [Related]  

  • 12. Recalcitrant pyoderma gangrenosum treated with thalidomide.
    Federman GL; Federman DG
    Mayo Clin Proc; 2000 Aug; 75(8):842-4. PubMed ID: 10943240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.
    Shenefelt PD
    Cutis; 1996 May; 57(5):315-9. PubMed ID: 8726710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
    Brenner M; Ruzicka T; Plewig G; Thomas P; Herzer P
    Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyoderma gangrenosum in a patient with essential thrombocythemia.
    King KW; Murray A
    J Cutan Med Surg; 2000 Apr; 4(2):107-9. PubMed ID: 11179935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream.
    Patel GK; Rhodes JR; Evans B; Holt PJ
    J Dermatolog Treat; 2004 Apr; 15(2):122-5. PubMed ID: 15204166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.
    Low ZM; Mar A
    Australas J Dermatol; 2018 May; 59(2):131-134. PubMed ID: 29205260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blastomycosis-like pyoderma (Pyoderma vegetans) responding to antibiotics and topical disodium chromoglycate.
    Rongioletti F; Semino M; Drago F; Blangetti MG; Rebora A
    Int J Dermatol; 1996 Nov; 35(11):828-30. PubMed ID: 8915745
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary pyoderma gangrenosum without cutaneous manifestations.
    Sakata KK; Penupolu S; Colby TV; Gotway MB; Wesselius LJ
    Clin Respir J; 2016 Jul; 10(4):508-11. PubMed ID: 25354722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.